In this study, we hypothesized klotho could inhibit the PI3K/Akt pathway and further to alleviate the resistance of lung cancer cells to cisplatin and may serve a potent candidate for the gene therapy of lung cancer. The gene discussed is AKT1; the disease is lung carcinoma.